Suchergebnisse - "Zweegman, Sonja"

PubPharm (397)

1

Monoclonal Antibodies in the Treatment of Multiple Myeloma

enthalten in: Hematology/oncology clinics of North America | 2024

von van de Donk, N. | Zweegman, S.

2

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : data from five randomized, controlled, phase III trials in 3700 patients

enthalten in: Leukemia | 2024

von Mai, E. | Hielscher, T. | Bertsch, U. | +26

3

Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma : importance of immunoglobulin supplementation

enthalten in: Blood advances | 2024

von Frerichs, K. | Verkleij, C. | Mateos, M. | +21

4

Single-cell transcriptomic analysis of NK cell dynamics in myeloma patients reveal persistent reduction of cytotoxic NK cells from diagnosis to relapse

enthalten in: bioRxiv.org | 2023

von Tahri, S. | de Jong, M. | Fokkema, C. | +18

5

Maintain maintenance in multiple myeloma?

enthalten in: Blood | 2023

von Zweegman, S. | van de Donk, N.

CommentOn: Blood. 2023 Nov 2;142(18):1518-1528. - PMID 37506339

6

T-cell redirecting bispecific and trispecific antibodies in multiple myeloma beyond BCMA

enthalten in: Current opinion in oncology | 2023

von van de Donk, N. | O'Neill, C. | de Ruijter, M. | +2

7

Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129) : final analysis of a non-randomised, multicentre, phase 2 study

enthalten in: The Lancet. Oncology | 2023

von van de Donk, N. | Minnema, M. | van der Holt, B. | +25

8

Specific Targeting of Multiple Myeloma by Dual Split-signaling Chimeric Antigen Receptor T cells Directed against CD38 and CD138

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von van der Schans, J. | Wang, Z. | van Arkel, J. | +11

9

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients : Long-term Results of HOVON-126/NMSG 21.13

enthalten in: HemaSphere | 2023

von Groen, K. | Schjesvold, F. | van der Holt, B. | +22

10

Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma : an open-label phase 2 trial

enthalten in: EClinicalMedicine | 2023

von Groen, K. | Stege, C. | Nasserinejad, K. | +26

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[40]